8-K - Instil Bio, Inc. | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

Instil Bio, Inc. dismissed Deloitte & Touche LLP and appointed RSM US LLP as its independent registered public accounting firm effective April 1, 2026, with no disagreements or reportable events.

Key Takeaways

1Audit Committee dismissed Deloitte effective April 1, 2026, and appointed RSM US LLP for fiscal year ending December 31, 2026.

2Deloitte's audit reports for fiscal years 2024 and 2025 contained no adverse opinions, qualifications, or modifications.

3No disagreements with Deloitte on accounting principles, disclosures, or audit scope through April 1, 2026.

4No reportable events as defined in Item 304(a)(1)(v) of Regulation S-K during the period.

5Deloitte confirmed agreement with most disclosures in Exhibit 16.1 letter dated April 3, 2026.

6No prior consultations with RSM on accounting or audit matters.

Current Report Details

Event Type

Auditor Change

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

4.01

Changes in Registrant’s Certifying Accountant. On April 1, 2026, the Audit Committee of the Board of Directors of Instil Bio, Inc. (the “Company”) approved the

Auditor Change

9.01

Financial Statements and Exhibits. (d) Exhibits: Exhibit No. | Col2: Description (d) Exhibits: 16.1 | Col2: Letter from Deloitte & Touche LLP to the Securities

Exhibits Only

Exhibits (2)

16.1

EX-16.1

8-K